Polyethylene glycol conjugation of recombinant methioninase for cancer therapy

Protein Expression and Purification

Volumn 12, Issue 1, 1998, Pages 45-52

  Tan, Yuying ^a   Sun, Xinghua ^a   Xu, Mingxu ^a   An, Zili ^a   Tan, Xuezhong ^a   Tan, Xiuying ^a   Han, Qinghong ^a   Miljkovic, Dusan A ^a   Yang, Meng ^a   Hoffman, Robert M ^a  

^a ANTICANCER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANION EXCHANGE CHROMATOGRAPHY; ANTINEOPLASTIC AGENT; BUFFER; CANCER CELL; CANCER THERAPY; CLONING; CONJUGATION; ENZYME ACTIVITY; GEL FILTRATION; HALF LIFE TIME; MACROGOL; MASS SPECTROMETRY; METHIONINE; METHIONINE GAMMA LYASE; METHOXYPOLYETHYLENE GLYCOL PROPIONIC ACID; MOLECULAR WEIGHT; N HYDROXYSUCCINIMIDE DERIVATIVE;

ESCHERICHIA COLI; PSEUDOMONAS PUTIDA;

EID: 0032007236     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1006/prep.1997.0805     Document Type: Article

References (23)

1. Hoffman R. M., Erbe R. W. Highin vivo. Proc. Natl. Acad. Sci. USA. 73:1976;1523-1527.
2. Hoffman R. M. Altered methionine metabolism, DNA methylation, and oncogene expression in carcinogenesis: A review and synthesis. Biochem. Biophys. Acta. 738:1984;49-87.
3. Mecham J. O., Rowitch D., Wallace C. D., Stern P. H., Hoffman R. M. The metabolic defect of methionine dependence occurs frequently in human tumor cell lines. Biochem. Biophys. Res. Commun. 117:1983;429-434.
4. Guo H., Herrera H., Groce A., Hoffman R. M. Expression of the biochemical defect of methionine dependence in fresh patient tumors in primary histoculture. Cancer Res. 53:1993;2479-2483.
5. Kreis W., Goodenow M. Methionine requirement and replacement by homocysteine in tissue cultures of selected rodent and human malignant and normal cells. Cancer Res. 38:1978;2259-2262.
6. Guo H., Lishko V., Herrera H., Groce A., Kubota T., Hoffman R. M. Therapeutic tumor specific cell-cycle block induced by methionine starvationin vivo. Cancer Res. 53:1993;5676-5679.
7. Goseki N., Yamazaki S., Shimojyu K., Kando F., Maruyama M., Endo M., Koike M., Takahashi H. Synergistic effect of methionine-depleting total parenteral nutrition with 5-fluorouracil on human gastric cancer: A randomized, prospective clinical trial. Jpn. J. Cancer Res. 86:1995;484-489.
8. Goseki N., Yamazaki S., Endo M., Onodera T., Kosaski G., Hibino Y., Kuwahata T. Antitumor effect of methionine-depleting total parenteral nutrition with doxorubicin administration on Yoshida sarcoma-bearing rats. Cancer. 69:1992;1865-1872.
9. Lishko V. K., Lishko O. V., Hoffman R. M. The preparation of endotoxin-freeLLPseudomonas putida. Protein Expression Purif. 4:1993;529-533.
10. Tan Y., Xu M., Guo H., Sun X., Kubota T., Hoffman R. M. Anticancer efficacy of methioninasein vivo. Anticancer Res. 16:1996;3931-3936.
11. Tan Y., Zavala J. Sr., Xu M., Zavala J. Jr., Hoffman R. M. Serum methionine depletion without side effects by methioninase in metastatic breast cancer patients. Anticancer Res. 16:1996;3937-3942.
12. Tan Y., Xu M., Tan X. Z., Tan X., Wang X., Saikawa S., Nagahama T., Sun X., Lenz M., Hoffman R. M. Overexpression and large-scale production of recombinantL. Protein Expression Purif. 9:1997;233-245.
13. Inoue H., Inagaki K., Sugimoto M., Esaki N., Soda K., Tanaka H. Structural analysis of theLPseudomonas putida. J. Biochem. 117:1995;1120-1125.
14. Hori H., Takabayashi K., Orvis L., Carson D. A., Nobori T. Gene cloning and characterization ofPseudomonas putidaL. Cancer Res. 56:1996;2116-2122.
15. Tan Y., Zavala J., Han Q., Xu M., Sun X., Tan X Z., Tan X., Magana R., Geller J., Hoffman R. M. Recombinant methioninase infusion reduces the biochemical endpoint of serum methionine with minimal toxicity in high-stage cancer patients. Anticancer Res. 1997.
16. Jones B. N., Gilligan J. P. O-Phthaldialdehyde precolumn derivatization and reversed-phase high-performance liquid chromatography of polypeptide hydrolysates and physiological fluids. J. Chromatogr. 266:1983;471-482.
17. Katre N. V., Knauf M. J., Laird W. J. Chemical modification of recombinant interleukin 2 by polyethylene glycol increases its potency in the murine Meth A sarcoma model. Proc. Natl. Acad. Sci. USA. 84:1987;1487-1491.
18. Fanucchi M., Glaspy J., Crawford J., Garst J., Figlin R., Sheridan W., Menchaca D., Tomita D., Ozer H., Harker L. Effects of polyethelene glycol-conjugated recombinant human megakaryocyte growth and development factor on platelet counts after chemotherapy for lung cancer. New Engl. J. Med. 336:1997;404-409.
19. 2. Leukemia Res. 15:1991;525-530.
20. Hershfield M. S., Chaffee S., Koro-Johnson L., Mary A., Smith A. A., Short S. A. Use of site-directed mutagenesis to enhance the epitope-shielding effect of covalent modification of proteins with polyethylene glycol. Proc. Natl. Acad. Sci USA. 88:1991;7185-7189.
21. Biffoni M., Battaglia A., Borrelli F., Cantelmo A., Galli G., Eshkol A. Allergenic potential of gonadotrophic preparations in experimental animals : relevance of purity. Human Reprod. 9:1994;1845-1848.
22. Brumeanu T.-D., Zaghouani H., Bona C. Purification of antigenized immunoglobulins derivatized with monomethoxypolyethylene glycol. J. Chromatogr. A. 696:1995;219-225.
23. Bovara R., Carrea G., Gioacchini A. M., Riva S., Secundo F. Activity, stability and conformation of methoxypoly (ethylene glycol)-subtilisin at different concentrations of water in dioxane. Biotechnol. Bioeng. 54:1997;50-57.